300357 Stock Overview
A biopharmaceutical company, engages in the research, development, production, and sale of pharmaceutical products for the diagnosis and treatment of allergic diseases in China and internationally. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 4/6 |
Past Performance | 5/6 |
Financial Health | 5/6 |
Dividends | 4/6 |
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥22.18 |
52 Week High | CN¥30.30 |
52 Week Low | CN¥16.32 |
Beta | 0.68 |
11 Month Change | -11.17% |
3 Month Change | 30.78% |
1 Year Change | -25.99% |
33 Year Change | -60.75% |
5 Year Change | -51.70% |
Change since IPO | -4.56% |
Recent News & Updates
Recent updates
Shareholder Returns
300357 | CN Pharmaceuticals | CN Market | |
---|---|---|---|
7D | -5.4% | -1.5% | -2.1% |
1Y | -26.0% | -9.4% | 2.8% |
Return vs Industry: 300357 underperformed the CN Pharmaceuticals industry which returned -9.4% over the past year.
Return vs Market: 300357 underperformed the CN Market which returned 2.8% over the past year.
Price Volatility
300357 volatility | |
---|---|
300357 Average Weekly Movement | 10.9% |
Pharmaceuticals Industry Average Movement | 7.3% |
Market Average Movement | 8.3% |
10% most volatile stocks in CN Market | 12.6% |
10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 300357's share price has been volatile over the past 3 months compared to the CN market.
Volatility Over Time: 300357's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2002 | 1,709 | Gengxi Hu | www.wolwobiotech.com |
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceutical products for the diagnosis and treatment of allergic diseases in China and internationally. The company offers Changdi, a farinae farinae drops; Changhao, an artemisia annua pollen allergen sublingual drops; Changdian, a dust mite skin prick diagnostic kits; and Changdian II, a house dust mite skin pricking diagnostic kits. It also involved in the research and development of stem cells and medical artificial intelligence solutions.
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Fundamentals Summary
300357 fundamental statistics | |
---|---|
Market cap | CN¥11.61b |
Earnings (TTM) | CN¥312.29m |
Revenue (TTM) | CN¥904.64m |
37.2x
P/E Ratio12.8x
P/S RatioIs 300357 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
300357 income statement (TTM) | |
---|---|
Revenue | CN¥904.64m |
Cost of Revenue | CN¥43.86m |
Gross Profit | CN¥860.78m |
Other Expenses | CN¥548.49m |
Earnings | CN¥312.29m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.60 |
Gross Margin | 95.15% |
Net Profit Margin | 34.52% |
Debt/Equity Ratio | 1.5% |
How did 300357 perform over the long term?
See historical performance and comparison